The US Department of Health and Human Services has announced that a grant of up to $200,000 is available for “Assessment of Intersubject Variability in Small Airway Delivery with Oral Inhalation Drug Products.” One grant will be awarded.
According to the March 15, 2016 announcement, “FDA’s CDER is seeking depositional data obtained with a computational modeling approach for small airway delivery to adults with orally inhaled drug products (OIDPs) that are indicated for management of asthma. Possible sources of intersubject variability include lengths and diameters of various airway segments, heterogeneous or homogeneous constriction, and inhalation patterns. An expected outcome is regional deposition data for reference listed drugs that can indicate whether or not the drug product targets small airways in asthmatic patients and the key product attributes that affects the deposition.”
US and non-US educational institutions, governments, non-profit organizations, and for-profit organizations are all eligible to apply. Applications should be submitted by 11:59 p.m. Eastern time on May 16, 2016.
Read the HHS funding opportunity announcement
